Metabolism and regional cerebral blood volume in autoimmune inflammatory demyelinating lesions mimicking malignant gliomas.
Dynamic susceptibility contrast (DSC) magnetic resonance imaging (MRI) and MR spectroscopy are thought to differentiate tumefactive autoimmune inflammatory demyelinating lesions from glial brain tumours. The aim of this work is to evaluate whether regional cerebral blood volume (rCBV), as well as choline (Cho), N-acetyl-aspartate (NAA) and myo-inositol (mIns) concentrations differ between tumefactive lesions and World Health Organization (WHO) grade II-III gliomas. Five patients with single autoimmune inflammatory demyelinating lesions and nine patients with WHO grade II and III gliomas were examined by DSC-MRI and by two-dimensional (2D) 1H MR spectroscopic imaging (1H-MRSI). rCBV values and metabolite concentrations were normalised to the respective values of the contralateral hemisphere. Normalised rCBV in the tumefactive lesions (mean 2.89, range 1.98-6.74) was in the some high level as in gliomas (mean 2.77, range 1.43-6.22). 1H-MRSI revealed increased normalised choline concentrations in five of six examinations of autoimmune lesions (mean 1.4, range 1.06-1.8) and in eight of nine gliomas (mean 1.35, range 0.92-1.73). Tumefactive autoimmune inflammatory demyelinating lesions not only have imaging appearance of gliomas but may also imitate marked increase of rCBV and Cho in WHO grade II-III gliomas.
Blasel
Stella
S
Institute of Neuroradiology, University of Frankfurt, Department of Anaesthesia, Schleusenweg 2-16, 60528, Frankfurt, Germany. Stella.Blasel@kgu.de
Pfeilschifter
Waltraud
W
Jansen
Viola
V
Mueller
Klaus
K
Zanella
Friedhelm
F
Hattingen
Elke
E
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001224:Aspartic Acid / Q000031:analogs & derivatives / Q000378:metabolism; D001810:Blood Volume / Q000502:physiology*; D001932:Brain Neoplasms / Q000175:diagnosis / Q000378:metabolism* / Q000473:pathology*; D002560:Cerebrovascular Circulation / Q000502:physiology*; D002648:Child; D002794:Choline / Q000378:metabolism; D020278:Demyelinating Autoimmune Diseases, CNS / Q000175:diagnosis / Q000378:metabolism* / Q000473:pathology*; D003937:Diagnosis, Differential; D005189:False Positive Reactions; D005260:Female; D005910:Glioma / Q000175:diagnosis / Q000378:metabolism* / Q000473:pathology*; D006801:Humans; D008279:Magnetic Resonance Imaging; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D008875:Middle Aged; D009460:Neurologic Examination; D055815:Young Adult
D001224:Aspartic Acid; C000179:N-acetylaspartate; D002794:Choline
AJNR Am J Neuroradiol. 1999 Oct;20(9):1619-27
10543631
Ann Neurol. 2005 Dec;58(6):840-6
16283615
Ann Neurol. 1992 Mar;31(3):235-41
1637131
Neuroradiology. 2007 May;49(5):393-409
17333161
Radiology. 2002 Apr;223(1):11-29
11930044
Magn Reson Med. 1996 Nov;36(5):715-25
8916022
J Clin Pathol. 1994 Feb;47(2):129-33
8132826
Am J Surg Pathol. 1993 Jun;17(6):537-45
8333553
J Neurol Neurosurg Psychiatry. 2009 Dec;80(12):1330-6
19546105
Eur Radiol. 2006 Jan;16(1):180-6
16402258
AJNR Am J Neuroradiol. 2003 Nov-Dec;24(10):1989-98
14625221
J Neurol. 2006 Feb;253(2):224-30
16307201
Neuroimaging Clin N Am. 1999 May;9(2):309-31
10318717
Radiology. 1999 Feb;210(2):519-27
10207439
Radiology. 2004 Jun;231(3):645-52
15163806
Radiology. 1989 Aug;172(2):541-8
2748837
AJNR Am J Neuroradiol. 2005 Jun-Jul;26(6):1539-47
15956527
Brain. 2004 Jan;127(Pt 1):111-9
14570816
J Pathol. 2003 Oct;201(2):319-27
14517850
AJR Am J Roentgenol. 1998 Dec;171(6):1479-86
9843274
J Magn Reson Imaging. 2007 Aug;26(2):427-31
17654728
NMR Biomed. 2008 Mar;21(3):233-41
17562554
J Neuropathol Exp Neurol. 2002 Oct;61(10):914-25
12387457
Magn Reson Med. 1993 Dec;30(6):672-9
8139448
FASEB J. 1997 May;11(6):457-65
9194526
Ann Neurol. 2000 Jun;47(6):707-17
10852536